|
Volumn 62, Issue 11, 2002, Pages 3106-3112
|
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHEMOKINE RECEPTOR CCR1;
CHEMOKINE RECEPTOR CCR2;
CHEMOKINE RECEPTOR CCR3;
CHEMOKINE RECEPTOR CCR4;
CHEMOKINE RECEPTOR CCR5;
CHEMOKINE RECEPTOR CXCR1;
CHEMOKINE RECEPTOR CXCR2;
CHEMOKINE RECEPTOR CXCR3;
CHEMOKINE RECEPTOR CXCR4;
CHEMOKINE RECEPTOR CXCR4 ANTAGONIST;
MESSENGER RNA;
MONOCLONAL ANTIBODY;
STROMAL CELL DERIVED FACTOR 1;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
APOPTOSIS;
ARTICLE;
CELL MIGRATION;
CELL PROLIFERATION;
CONTROLLED STUDY;
EXTRAVASATION;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
IN VIVO STUDY;
MOUSE;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PRIORITY JOURNAL;
PSEUDOPODIUM;
SCID MOUSE;
TUMOR GROWTH;
ANIMALS;
ANTIBODIES, MONOCLONAL;
APOPTOSIS;
CELL DIVISION;
CELL MOVEMENT;
HUMANS;
LYMPHOMA, NON-HODGKIN;
MICE;
MICE, INBRED NOD;
MICE, SCID;
RECEPTORS, CXCR4;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0036606772
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (208)
|
References (26)
|